Genomics BioSci & Tech. Co.,Ltd. (4195)의 가격은 얼마입니까?

Genomics BioSci & Tech. Co.,Ltd. (4195)의 가격은 $0.54058348입니다.

Genomics BioSci & Tech. Co.,Ltd. (4195)의 시가 총액은 무엇입니까?

Genomics BioSci & Tech. Co.,Ltd. (4195)의 시가 총액은 $39.16M입니다.

Genomics BioSci & Tech. Co.,Ltd. (4195) 배당금

Genomics BioSci & Tech. Co.,Ltd. specializes in providing a comprehensive array of services within the field of genomic sequencing. Its core offerings encompass standard and intricate DNA sequencing, including TAF-certified options, with clients also benefiting from complimentary sequencing primer and primer walking services. Beyond sequencing, the company is proficient in synthesizing peptides, genes, and oligonucleotides. Furthermore, its analytical capabilities extend to crucial laboratory services such as sample preparation, gene expression analysis, genotyping, DNA methylation analysis, and microbial identification. The firm also delivers advanced sequencing solutions, including genome-level, targeted, gene regulation, and metagenomic sequencing, alongside cutting-edge third-generation sequencing technologies. To support these services, it offers integrated sequencing platforms and streamlined workflows. Additionally, Genomics BioSci & Tech. Co.,Ltd. provides specialized diagnostic screenings, such as non-invasive prenatal testing (NIPT), spinal muscular atrophy (SMA) carrier screening, and fragile X syndrome premutation screening. Established in 2001, the company's headquarters are located in New Taipei City, Taiwan.

연도	배당금 (주식 분할 조정됨)	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

배당금 (주식 분할 조정됨)

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도	배당금	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

배당금

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	배당 지급 횟수	국가
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
CSL Limited CSL.AX	64.00%	AU
Moderna, Inc. MRNA.US	0.00%	US
Lonza Group AG LONN.SW	0.00%	CH

회사

배당 지급 횟수

국가